|
LOT
|
Frequency, N
|
Attrition, %
|
Deaths, n (%)
|
No subsequent treatment in follow-up, n (%)
|
Subsequent treatment, n (%)
|
Mean ± SD treatment duration, months (median)
|
|---|
|
Non-transplant
|
|
1
|
22,062
|
–
|
2841 (12.9)
|
9716 (44.0)
|
9505 (43.1)
|
6.9 ± 9.6 (3.6)
|
|
2
|
9505
|
56.9
|
1155 (12.2)
|
3168 (33.3)
|
5182 (54.5)
|
7.5 ± 9.5 (4.1)
|
|
3
|
5182
|
45.5
|
636 (12.3)
|
1575 (30.3)
|
2971 (57.3)
|
6.5 ± 8.0 (3.7)
|
|
4
|
2971
|
42.7
|
364 (12.3)
|
901 (30.3)
|
1706 (57.4)
|
5.7 ± 6.6 (3.4)
|
|
5
|
1706
|
42.6
|
209 (12.3)
|
508 (29.8)
|
989 (58.0)
|
5.5 ± 6.4 (3.2)
|
|
Transplant
|
|
1
|
2763
|
–
|
36 (1.3)
|
543 (19.6)
|
2184 (79.0)
|
6.3 ± 8.0 (4.2)
|
|
2
|
2184
|
21.0
|
60 (2.7)
|
613 (28.1)
|
1511 (69.2)
|
6.1 ± 9.2 (2.7)
|
|
3
|
1511
|
30.8
|
63 (4.2)
|
494 (32.7)
|
954 (63.1)
|
7.4 ± 9.8 (3.6)
|
|
4
|
954
|
36.9
|
60 (6.3)
|
276 (28.9)
|
618 (64.8)
|
6.6 ± 9.4 (3.4)
|
|
5
|
618
|
35.2
|
49 (7.9)
|
180 (29.1)
|
389 (62.9)
|
5.6 ± 6.2 (3.3)
|
- LOT Line of therapy, SD Standard deviation
